Why Recombinant Protein is a Manufacturing Problem, Not a Discovery Problem
Artificial Intelligence has transformed protein discovery, making the identification of new molecules faster than ever. Today, the biggest challenge in recombinant proteins and biologics is no longer discovery—it is manufacturing them reliably, affordably, and at commercial scale.
Biopharmaceutical Manufacturing | 24/09/2026
Advancing Biologics Manufacturing Through Innovation
Sachin Joshi, Managing Director and Co-Founder, PharmNXT, discusses biologics supply chains, single-use technologies, localisation, and the future of biologics manufacturing, in an exclusive interview with Pharma Industrial India.
Biopharmaceutical Manufacturing | 07/07/2026
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy